Scrip
Intercytex nears end as Pfizer snaps up Axordia assets
24 November 2009
Sukaina Virji
Please Login to read the full article.
24 November 2009
Sukaina Virji
Intercytex continues to wind down operations with the sale of the assets from its wholly owned subsidiary Axordia to Pfizer for $750,000.
Intercytex acquired Axordia last year for £1.7 million (scripnews.com, December 29th, 2008). The move gave Intercytex access to a programme for...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sanofi-Aventis pulls out of TroVax but in ocular deal with Oxford BioMedica
- Pfizer and UCL to develop stem-cell therapies for macular degeneration
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
- QLT sells Eligard franchise to Tolmar in $230 million deal
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
